Gujarat Alkalies and Chemicals Limited (NSE:GUJALKALI)

Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 1, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	42,098	42,535	49,456	42,972	65,840	25,321
Market Cap Growth	-13.99%	-13.99%	15.09%	-34.73%	160.02%	54.62%
Enterprise Value	46,176	45,630	51,215	45,061	69,427	25,245
Last Close Price	573.25	579.20	662.23	557.14	844.16	319.42
PE Ratio	-	-	-	10.49	11.76	15.28
PS Ratio	1.03	1.04	1.30	0.95	1.75	1.04
PB Ratio	0.70	0.71	0.81	0.70	1.12	0.47
P/TBV Ratio	0.70	0.71	0.81	0.70	1.12	0.47
P/FCF Ratio	75.53	76.31	-	15.52	-	-
P/OCF Ratio	11.04	11.16	74.24	4.48	8.96	6.01
EV/Sales Ratio	1.13	1.12	1.35	1.00	1.85	1.04
EV/EBITDA Ratio	16.52	12.66	34.02	3.93	7.06	7.11
EV/EBIT Ratio	-	-	-	5.16	8.79	13.71
EV/FCF Ratio	82.84	81.86	-	16.27	-	-
Debt / Equity Ratio	0.09	0.09	0.09	0.10	0.10	0.09
Debt / EBITDA Ratio	1.56	1.56	3.55	0.52	0.60	1.39
Debt / FCF Ratio	10.06	10.06	-	2.15	-	-
Asset Turnover	0.50	0.50	0.47	0.55	0.50	0.37
Inventory Turnover	6.35	6.35	6.61	6.47	7.01	6.20
Quick Ratio	0.45	0.45	0.59	0.94	0.87	1.21
Current Ratio	1.13	1.13	1.23	1.68	1.49	1.78
Return on Equity (ROE)	-1.08%	-1.08%	-3.88%	6.80%	9.93%	3.33%
Return on Assets (ROA)	-0.24%	-0.24%	-1.70%	6.69%	6.52%	1.76%
Return on Capital (ROIC)	-0.30%	-0.30%	-2.09%	8.25%	7.98%	2.16%
Return on Capital Employed (ROCE)	-	-	-	11.70%	10.90%	2.80%
Earnings Yield	-1.55%	-1.53%	-4.79%	9.53%	8.50%	6.54%
FCF Yield	1.32%	1.31%	-3.33%	6.44%	-2.64%	-14.73%
Dividend Yield	2.72%	2.73%	-	4.23%	1.19%	2.50%
Payout Ratio	-	-	-	17.96%	10.52%	35.53%
Buyback Yield / Dilution	0.03%	0.03%	-	-	-	-
Total Shareholder Return	2.74%	2.76%	-	4.23%	1.19%	2.50%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.